Previous Article | Next Article 
Journal of Virology, October 2002, p. 10015-10019, Vol. 76, No. 19
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.19.10015-10019.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Crystal Structures of Zidovudine- or Lamivudine-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptases Containing Mutations at Codons 41, 184, and 215
P. P. Chamberlain,1,2 J. Ren,1 C. E. Nichols,1,2 L. Douglas,1 J. Lennerstrand,3,
B. A. Larder,3 D. I. Stuart,1,2 and D. K. Stammers1,2*
Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN,1
Oxford Centre for Molecular Sciences, Oxford OX1 3QT,2
Visible Genetics, Cambridge CB4 0GA, United Kingdom3
Received 25 March 2002/
Accepted 30 June 2002
Six structures of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing combinations of resistance mutations for zidovudine (AZT) (M41L and T215Y) or lamivudine (M184V) have been determined as inhibitor complexes. Minimal conformational changes in the polymerase or nonnucleoside RT inhibitor sites compared to the mutant RTMC (D67N, K70R, T215F, and K219N) are observed, indicating that such changes may occur only with certain combinations of mutations. Model building M41L and T215Y into HIV-1 RT-DNA and docking in ATP that is utilized in the pyrophosphorolysis reaction for AZT resistance indicates that some conformational rearrangement appears necessary in RT for ATP to interact simultaneously with the M41L and T215Y mutations.
* Corresponding author. Mailing address: Division of Structural Biology, The Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, United Kingdom. Phone: 44-1865-287-565. Fax: 44-1865-287-547. E-mail:
daves{at}strubi.ox.ac.uk.
Present address: Division of Clinical Virology, Karolinska Institute F68, Huddinge University Hospital, S-141 86 Huddinge, Sweden.
Journal of Virology, October 2002, p. 10015-10019, Vol. 76, No. 19
0022-538X/02/$04.00+0 DOI: 10.1128/JVI.76.19.10015-10019.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Li, N., Wang, Y., Pothukuchy, A., Syrett, A., Husain, N., Gopalakrisha, S., Kosaraju, P., Ellington, A. D.
(2008). Aptamers that recognize drug-resistant HIV-1 reverse transcriptase. Nucleic Acids Res
36: 6739-6751
[Abstract]
[Full Text]
-
Lennerstrand, J., Chu, C. K., Schinazi, R. F.
(2007). Biochemical Studies on the Mechanism of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistance to 1-({beta}-D-Dioxolane)Thymine Triphosphate. Antimicrob. Agents Chemother.
51: 2078-2084
[Abstract]
[Full Text]
-
Meyer, P. R., Smith, A. J., Matsuura, S. E., Scott, W. A.
(2006). Chain-Terminating Dinucleoside Tetraphosphates Are Substrates for DNA Polymerization by Human Immunodeficiency Virus Type 1 Reverse Transcriptase with Increased Activity against Thymidine Analogue-Resistant Mutants. Antimicrob. Agents Chemother.
50: 3607-3614
[Abstract]
[Full Text]
-
Hu, Z., Giguel, F., Hatano, H., Reid, P., Lu, J., Kuritzkes, D. R.
(2006). Fitness Comparison of Thymidine Analog Resistance Pathways in Human Immunodeficiency Virus Type 1. J. Virol.
80: 7020-7027
[Abstract]
[Full Text]
-
Parikh, U. M., Bacheler, L., Koontz, D., Mellors, J. W.
(2006). The K65R Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Exhibits Bidirectional Phenotypic Antagonism with Thymidine Analog Mutations.. J. Virol.
80: 4971-4977
[Abstract]
[Full Text]
-
Miranda, L. R., Gotte, M., Kuritzkes, D. R.
(2005). The L74V Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Counteracts Enhanced Excision of Zidovudine Monophosphate Associated with Thymidine Analog Resistance Mutations. Antimicrob. Agents Chemother.
49: 2648-2656
[Abstract]
[Full Text]
-
Meyer, P. R., Smith, A. J., Matsuura, S. E., Scott, W. A.
(2004). Effects of Primer-Template Sequence on ATP-dependent Removal of Chain-terminating Nucleotide Analogues by HIV-1 Reverse Transcriptase. J. Biol. Chem.
279: 45389-45398
[Abstract]
[Full Text]
-
Boyer, P. L., Imamichi, T., Sarafianos, S. G., Arnold, E., Hughes, S. H.
(2004). Effects of the {Delta}67 Complex of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Nucleoside Analog Excision. J. Virol.
78: 9987-9997
[Abstract]
[Full Text]
-
Pata, J. D., Stirtan, W. G., Goldstein, S. W., Steitz, T. A.
(2004). Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors. Proc. Natl. Acad. Sci. USA
101: 10548-10553
[Abstract]
[Full Text]
-
Matamoros, T., Franco, S., Vazquez-Alvarez, B. M., Mas, A., Martinez, M. A., Menendez-Arias, L.
(2004). Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain: EFFECT OF MUTATIONS D67N AND T215Y ON REMOVAL OF THYMIDINE NUCLEOTIDE ANALOGUES FROM BLOCKED DNA PRIMERS. J. Biol. Chem.
279: 24569-24577
[Abstract]
[Full Text]
-
Clavel, F., Hance, A. J.
(2004). HIV Drug Resistance. NEJM
350: 1023-1035
[Full Text]
-
Girouard, M., Diallo, K., Marchand, B., McCormick, S., Gotte, M.
(2003). Mutations E44D and V118I in the Reverse Transcriptase of HIV-1 Play Distinct Mechanistic Roles in Dual Resistance to AZT and 3TC. J. Biol. Chem.
278: 34403-34410
[Abstract]
[Full Text]
-
Meyer, P. R., Matsuura, S. E., Zonarich, D., Chopra, R. R., Pendarvis, E., Bazmi, H. Z., Mellors, J. W., Scott, W. A.
(2003). Relationship between 3'-Azido-3'-Deoxythymidine Resistance and Primer Unblocking Activity in Foscarnet-Resistant Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. J. Virol.
77: 6127-6137
[Abstract]
[Full Text]